Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

Tracks how stroke patients perceive using their arm during rehabilitation

Studies how stroke survivors' views of arm use relate to observed function during rehabilitation.

Plain-language title generated from the registry record
Registry title: Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation

Key facts

Where
Charleroi and Mons, BelgiumSee the 2 sites

Where in Belgium

  • Grand Hopital de CharleroiCharleroi, BelgiumTaking people
  • CHU HELORA site KennedyMons, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Grand Hôpital de Charleroi
Trial code
NCT06569771
Record updated
13 April 2026
Original description
This study is being carried out in the context of rehabilitation after stroke, where persistent upper limb weakness is a major challenge. It aims to explore the relationship between observed function and patients' perceived participation in use.Read full original descriptionShow less

Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation

This study is being carried out in the context of rehabilitation after stroke, where persistent upper limb weakness is a major challenge. It aims to explore the relationship between observed function and patients' perceived participation in use.

Inclusion: First stroke as defined by the World Health Organization; Upper limb paresis with a NIHSS National Institutes of Health Stroke Scale score > or = 1/4 for upper limb motor function.

Exclusion: Life expectancy <12 months; Inability to understand French; Pre-existing severe multiple disability affecting arm function; Presence of pre-existing central neurological pathologies; Mini-Mental State Examination < 21.

ClinicalTrials.gov NCT06569771